TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Livzon Pharmaceutical Group ( (HK:1513) ) has provided an announcement.
Livzon Pharmaceutical Group Inc. has announced the publication of its Articles of Association, pending shareholder approval, on the Shenzhen Stock Exchange website. This regulatory announcement is part of compliance with Hong Kong Stock Exchange rules, and it highlights the company’s ongoing commitment to transparency and governance, potentially impacting its market perception and stakeholder confidence.
The most recent analyst rating on (HK:1513) stock is a Buy with a HK$48.00 price target. To see the full list of analyst forecasts on Livzon Pharmaceutical Group stock, see the HK:1513 Stock Forecast page.
More about Livzon Pharmaceutical Group
Livzon Pharmaceutical Group Inc. operates in the pharmaceutical industry, focusing on the development, production, and sale of a wide range of pharmaceutical products. The company is based in Zhuhai, China, and is listed on the Shenzhen Stock Exchange, with a market focus on both domestic and international markets.
Average Trading Volume: 1,513,250
Technical Sentiment Signal: Buy
Current Market Cap: HK$34.39B
See more insights into 1513 stock on TipRanks’ Stock Analysis page.